Your session is about to expire
← Back to Search
Behavioural Intervention
CanCEASE + Health Navigator for Smoking Cessation (CanCEASE-2 Trial)
N/A
Waitlist Available
Led By Olivier Drouin, MD, MSc, MPH
Research Sponsored by St. Justine's Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 1 year
Awards & highlights
No Placebo-Only Group
Summary
"This trial aims to help parents who smoke quit in order to reduce children's exposure to second-hand smoke. The study will recruit 1000 participants from pediatric clinics in Montreal over 2.5 years
Who is the study for?
This trial is for parents or legal guardians who smoke, are over 18 years old, and accompany a child under 18 to pediatric clinics in Montreal. They must face at least one social challenge like job security or food access and speak French or English well enough for interviews.
What is being tested?
The study tests a smoking cessation program called CanCEASE with added Health Navigator support against usual care. Participants will be split into two groups: one receives the intervention immediately, while the other gets it after a year, with follow-ups at 6 and 12 months.
What are the potential side effects?
Since this trial involves behavioral support rather than medication, there may not be direct side effects as seen with drugs. However, participants might experience stress or anxiety related to lifestyle changes during their attempt to quit smoking.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ through study completion, an average of 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 1 year
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Aim 1 - 7-day abstinence
Aim 1 - Anabasine-confirmed quit
Aim 1 - Cotinine-confirmed quit
+12 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: CanCEASE with Health NavigatorExperimental Treatment1 Intervention
Participants assigned to this arm will receive smoking cessation resources, including instructions to access Nicotine Replacement Therapy (NRT) at Baseline, 6 and 12 months. They will also have the choice to schedule support sessions with a Health Navigator, which will be an individual with lived experience related to tobacco and trained to provide support for unmet social needs.
Group II: Care-as-usualActive Control1 Intervention
Participants assigned to this group will receive care as usually delivered in participating clinics and list of smoking cessation resources, including instructions to access Nicotine Replacement Therapy (NRT).
Find a Location
Who is running the clinical trial?
St. Justine's HospitalLead Sponsor
200 Previous Clinical Trials
85,240 Total Patients Enrolled
Olivier Drouin, MD, MSc, MPHPrincipal InvestigatorCHU Sainte-Justine Research Centre
1 Previous Clinical Trials
3,000 Total Patients Enrolled
Nicholas Chadi, MD, MPHPrincipal InvestigatorCHU Sainte-Justine Research Centre
1 Previous Clinical Trials
130 Total Patients Enrolled